US Stock MarketDetailed Quotes

AUTL Autolus Therapeutics

Watchlist

2.940
+0.100+3.52%

Close Nov 22 16:00 ET

2.910
-0.030-1.02%

Post 18:28 ET

782.40MMarket Cap-2409P/E (TTM)

Autolus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-90.95%-76.74M

-33.91%-51.08M

4.49%-40.51M

-29.63%-145.59M

-70.49%-24.83M

-25.97%-40.19M

-23.82%-38.15M

-21.09%-42.42M

4.71%-112.31M

-59.05%-14.57M

Net income from continuing operations

-79.05%-82.09M

-27.92%-58.27M

-32.35%-52.69M

-40.01%-208.38M

-186.34%-77.17M

-7.20%-45.85M

-8.31%-45.55M

-7.42%-39.81M

-4.75%-148.84M

35.32%-26.95M

Operating gains losses

-338.04%-14.09M

83.73%-533K

108.33%1.68M

-184.53%-3.81M

-20.46%-7.26M

11.73%5.92M

---3.28M

--804K

571.28%4.51M

---6.03M

Depreciation and amortization

40.54%1.94M

25.33%1.9M

-4.90%1.81M

-11.55%6.57M

7.64%1.78M

-22.83%1.38M

-21.21%1.51M

-8.13%1.9M

-12.25%7.42M

-21.63%1.65M

Deferred tax

29.41%-168K

185.06%74K

-18.97%-232K

-267.91%-986K

-246.08%-466K

-48.75%-238K

65.61%-87K

-12.07%-195K

-272.22%-268K

175.95%319K

Other non cash items

91.52%11.65M

91.04%11.32M

244.06%20.4M

299.09%49.15M

353.13%31.22M

232.71%6.08M

227.58%5.93M

231.17%5.93M

154.99%12.32M

42.98%6.89M

Change In working capital

118.66%2M

-1,434.88%-8.92M

-2.24%-13.75M

-45.52%292K

287.64%23.8M

-775.90%-10.72M

272.16%668K

-237.06%-13.45M

30.73%536K

-66.23%6.14M

-Change in prepaid assets

5.47%-4.79M

-254.40%-6.67M

-150.19%-10.11M

223.62%13.36M

86.92%18.14M

52.56%-5.06M

194.03%4.32M

23.01%-4.04M

-262.45%-10.81M

-65.62%9.71M

-Change in payables and accrued expense

1,797.13%8.27M

-182.09%-834K

66.24%-2.46M

-96.95%489K

1,019.47%7.24M

-105.08%-487K

-75.72%1.02M

-550.12%-7.28M

517.75%16.03M

110.90%647K

-Change in other current liabilities

71.42%-1.48M

69.65%-1.42M

44.36%-1.18M

-189.20%-13.56M

---1.59M

---5.17M

---4.67M

---2.13M

-94.89%-4.69M

----

Cash from discontinued investing activities

Operating cash flow

-90.95%-76.74M

-33.91%-51.08M

4.49%-40.51M

-29.63%-145.59M

-70.49%-24.83M

-25.97%-40.19M

-23.82%-38.15M

-21.09%-42.42M

4.71%-112.31M

-59.05%-14.57M

Investing cash flow

Cash flow from continuing investing activities

-540.12%-9.59M

80.84%-841K

85.28%-533K

-1.34%-10.99M

-133.33%-1.48M

77.96%-1.5M

-66.25%-4.39M

-369.78%-3.62M

-22.40%-10.84M

60.06%-633K

Net PPE purchase and sale

-540.12%-9.59M

80.84%-841K

85.28%-533K

-1.34%-10.99M

-133.33%-1.48M

77.96%-1.5M

-66.25%-4.39M

-369.78%-3.62M

-22.40%-10.84M

60.06%-633K

Cash from discontinued investing activities

Investing cash flow

-540.12%-9.59M

80.84%-841K

85.28%-533K

-1.34%-10.99M

-133.33%-1.48M

77.96%-1.5M

-66.25%-4.39M

-369.78%-3.62M

-22.40%-10.84M

60.06%-633K

Financing cash flow

Cash flow from continuing financing activities

4,525.00%185K

-849.32%-2.08M

81,350.51%561.44M

-100.39%-883K

-99.99%23K

-96.08%4K

-219K

-69,000.00%-691K

-21.28%223.61M

51.62%223.51M

Net common stock issuance

--0

--549.98M

--0

-33.37%163.85M

----

Proceeds from stock option exercised by employees

4,525.00%185K

--125K

--285K

-76.92%27K

--23K

--4K

--0

-6.40%117K

--0

Net other financing activities

--0

-906.39%-2.2M

1,717.80%11.18M

-101.53%-910K

--0

---219K

-69,000.00%-691K

56.79%59.64M

--59.66M

Cash from discontinued financing activities

Financing cash flow

4,525.00%185K

-849.32%-2.08M

81,350.51%561.44M

-100.39%-883K

-99.99%23K

-96.08%4K

---219K

-69,000.00%-691K

-21.28%223.61M

51.62%223.51M

Net cash flow

Beginning cash position

129.66%706.96M

121.21%759.54M

-37.21%240.34M

23.20%382.76M

57.22%256.85M

42.01%307.83M

27.69%343.36M

23.20%382.76M

101.63%310.68M

-5.71%163.37M

Current changes in cash

-106.67%-86.14M

-26.31%-54M

1,213.57%520.39M

-256.73%-157.46M

-112.62%-26.29M

-7.99%-41.68M

-27.83%-42.76M

-30.53%-46.73M

-36.15%100.46M

52.42%208.31M

Effect of exchange rate changes

505.57%37.72M

-80.39%1.42M

-116.18%-1.19M

152.97%15.03M

-11.82%9.77M

37.13%-9.3M

138.71%7.23M

222.47%7.33M

-3,663.40%-28.38M

1,409.95%11.08M

End cash Position

156.39%658.54M

129.66%706.96M

121.21%759.54M

-37.21%240.34M

57.22%256.85M

42.01%307.83M

27.69%343.36M

23.20%382.76M

Free cash flow

-107.09%-86.33M

-22.07%-51.92M

10.85%-41.05M

-27.14%-156.57M

-73.10%-26.31M

-7.71%-41.69M

-27.17%-42.54M

-28.60%-46.04M

2.82%-123.15M

-41.48%-15.2M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-90.95%-76.74M	-33.91%-51.08M	4.49%-40.51M	-29.63%-145.59M	-70.49%-24.83M	-25.97%-40.19M	-23.82%-38.15M	-21.09%-42.42M	4.71%-112.31M	-59.05%-14.57M
Net income from continuing operations	-79.05%-82.09M	-27.92%-58.27M	-32.35%-52.69M	-40.01%-208.38M	-186.34%-77.17M	-7.20%-45.85M	-8.31%-45.55M	-7.42%-39.81M	-4.75%-148.84M	35.32%-26.95M
Operating gains losses	-338.04%-14.09M	83.73%-533K	108.33%1.68M	-184.53%-3.81M	-20.46%-7.26M	11.73%5.92M	---3.28M	--804K	571.28%4.51M	---6.03M
Depreciation and amortization	40.54%1.94M	25.33%1.9M	-4.90%1.81M	-11.55%6.57M	7.64%1.78M	-22.83%1.38M	-21.21%1.51M	-8.13%1.9M	-12.25%7.42M	-21.63%1.65M
Deferred tax	29.41%-168K	185.06%74K	-18.97%-232K	-267.91%-986K	-246.08%-466K	-48.75%-238K	65.61%-87K	-12.07%-195K	-272.22%-268K	175.95%319K
Other non cash items	91.52%11.65M	91.04%11.32M	244.06%20.4M	299.09%49.15M	353.13%31.22M	232.71%6.08M	227.58%5.93M	231.17%5.93M	154.99%12.32M	42.98%6.89M
Change In working capital	118.66%2M	-1,434.88%-8.92M	-2.24%-13.75M	-45.52%292K	287.64%23.8M	-775.90%-10.72M	272.16%668K	-237.06%-13.45M	30.73%536K	-66.23%6.14M
-Change in prepaid assets	5.47%-4.79M	-254.40%-6.67M	-150.19%-10.11M	223.62%13.36M	86.92%18.14M	52.56%-5.06M	194.03%4.32M	23.01%-4.04M	-262.45%-10.81M	-65.62%9.71M
-Change in payables and accrued expense	1,797.13%8.27M	-182.09%-834K	66.24%-2.46M	-96.95%489K	1,019.47%7.24M	-105.08%-487K	-75.72%1.02M	-550.12%-7.28M	517.75%16.03M	110.90%647K
-Change in other current liabilities	71.42%-1.48M	69.65%-1.42M	44.36%-1.18M	-189.20%-13.56M	---1.59M	---5.17M	---4.67M	---2.13M	-94.89%-4.69M	----
Cash from discontinued investing activities
Operating cash flow	-90.95%-76.74M	-33.91%-51.08M	4.49%-40.51M	-29.63%-145.59M	-70.49%-24.83M	-25.97%-40.19M	-23.82%-38.15M	-21.09%-42.42M	4.71%-112.31M	-59.05%-14.57M
Investing cash flow
Cash flow from continuing investing activities	-540.12%-9.59M	80.84%-841K	85.28%-533K	-1.34%-10.99M	-133.33%-1.48M	77.96%-1.5M	-66.25%-4.39M	-369.78%-3.62M	-22.40%-10.84M	60.06%-633K
Net PPE purchase and sale	-540.12%-9.59M	80.84%-841K	85.28%-533K	-1.34%-10.99M	-133.33%-1.48M	77.96%-1.5M	-66.25%-4.39M	-369.78%-3.62M	-22.40%-10.84M	60.06%-633K
Cash from discontinued investing activities
Investing cash flow	-540.12%-9.59M	80.84%-841K	85.28%-533K	-1.34%-10.99M	-133.33%-1.48M	77.96%-1.5M	-66.25%-4.39M	-369.78%-3.62M	-22.40%-10.84M	60.06%-633K
Financing cash flow
Cash flow from continuing financing activities	4,525.00%185K	-849.32%-2.08M	81,350.51%561.44M	-100.39%-883K	-99.99%23K	-96.08%4K	-219K	-69,000.00%-691K	-21.28%223.61M	51.62%223.51M
Net common stock issuance	--0	--0	--549.98M	--0	--0	--0	--0	--0	-33.37%163.85M	----
Proceeds from stock option exercised by employees	4,525.00%185K	--125K	--285K	-76.92%27K	--23K	--4K	--0	--0	-6.40%117K	--0
Net other financing activities	--0	-906.39%-2.2M	1,717.80%11.18M	-101.53%-910K	--0	--0	---219K	-69,000.00%-691K	56.79%59.64M	--59.66M
Cash from discontinued financing activities
Financing cash flow	4,525.00%185K	-849.32%-2.08M	81,350.51%561.44M	-100.39%-883K	-99.99%23K	-96.08%4K	---219K	-69,000.00%-691K	-21.28%223.61M	51.62%223.51M
Net cash flow
Beginning cash position	129.66%706.96M	121.21%759.54M	-37.21%240.34M	23.20%382.76M	57.22%256.85M	42.01%307.83M	27.69%343.36M	23.20%382.76M	101.63%310.68M	-5.71%163.37M
Current changes in cash	-106.67%-86.14M	-26.31%-54M	1,213.57%520.39M	-256.73%-157.46M	-112.62%-26.29M	-7.99%-41.68M	-27.83%-42.76M	-30.53%-46.73M	-36.15%100.46M	52.42%208.31M
Effect of exchange rate changes	505.57%37.72M	-80.39%1.42M	-116.18%-1.19M	152.97%15.03M	-11.82%9.77M	37.13%-9.3M	138.71%7.23M	222.47%7.33M	-3,663.40%-28.38M	1,409.95%11.08M
End cash Position	156.39%658.54M	129.66%706.96M	121.21%759.54M	-37.21%240.34M	-37.21%240.34M	57.22%256.85M	42.01%307.83M	27.69%343.36M	23.20%382.76M	23.20%382.76M
Free cash flow	-107.09%-86.33M	-22.07%-51.92M	10.85%-41.05M	-27.14%-156.57M	-73.10%-26.31M	-7.71%-41.69M	-27.17%-42.54M	-28.60%-46.04M	2.82%-123.15M	-41.48%-15.2M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data